Abstract

BackgroundEndogenous small interfering (esi)RNAs repress mRNA levels and retrotransposon mobility in Drosophila somatic cells by poorly understood mechanisms. 21 nucleotide esiRNAs are primarily generated from retrotransposons and two inverted repeat (hairpin) loci in Drosophila culture cells in a Dicer2 dependent manner. Additionally, proteins involved in 3’ end processing, such as Symplekin, CPSF73 and CPSR100, have been recently implicated in the esiRNA pathway.ResultsHere we present evidence of overlap between two essential RNA metabolic pathways: esiRNA biogenesis and mRNA 3' end processing. We have identified a nucleus-specific interaction between the essential esiRNA cleavage enzyme Dicer2 (Dcr2) and Symplekin, a component of the core cleavage complex (CCC) required for 3' end processing of all eukaryotic mRNAs. This interaction is mediated by the N-terminal 271 amino acids of Symplekin; CCC factors CPSF73 and CPSF100 do not contact Dcr2. While Dcr2 binds the CCC, Dcr2 knockdown does not affect mRNA 3' end formation. RNAi-depletion of CCC components Symplekin and CPSF73 causes perturbations in esiRNA abundance that correlate with fluctuations in retrotransposon and hairpin esiRNA precursor levels. We also discovered that esiRNAs generated from retrotransposons and hairpins have distinct physical characteristics including a higher predominance of 22 nucleotide hairpin-derived esiRNAs and differences in 3' and 5' base preference. Additionally, retrotransposon precursors and derived esiRNAs are highly enriched in the nucleus while hairpins and hairpin derived esiRNAs are predominantly cytoplasmic similar to canonical mRNAs. RNAi-depletion of either CPSF73 or Symplekin results in nuclear retention of both hairpin and retrotransposon precursors suggesting that polyadenylation indirectly affects cellular localization of Dcr2 substrates.ConclusionsTogether, these observations support a novel mechanism in which differences in localization of esiRNA precursors impacts esiRNA biogenesis. Hairpin-derived esiRNAs are generated in the cytoplasm independent of Dcr2-Symplekin interactions, while retrotransposons are processed in the nucleus.

Highlights

  • Endogenous small interferingRNAs repress mRNA levels and retrotransposon mobility in Drosophila somatic cells by poorly understood mechanisms. 21 nucleotide endogenous small interfering RNAs (esiRNAs) are primarily generated from retrotransposons and two inverted repeat loci in Drosophila culture cells in a Dicer2 dependent manner

  • Results mRNA 3’ end processing factor Symplekin interacts with Dcr2 To identify potential novel core cleavage complex (CCC) binding partners, we immunoprecipitated endogenous Symplekin from crude Drosophila culture cell nuclear extracts and identified co-immunoprecipitating proteins by mass spectrometry (Additional file 2)

  • Endogenous Dcr2 co-immunoprecipitated with HA-tagged Symplekin (Fig. 1b), CPSF73 and CPSF100 (Fig. 1c) stably expressed in Dmel-2 cells

Read more

Summary

Introduction

Endogenous small interfering (esi)RNAs repress mRNA levels and retrotransposon mobility in Drosophila somatic cells by poorly understood mechanisms. 21 nucleotide esiRNAs are primarily generated from retrotransposons and two inverted repeat (hairpin) loci in Drosophila culture cells in a Dicer dependent manner. Endogenous small interfering (esi)RNAs repress mRNA levels and retrotransposon mobility in Drosophila somatic cells by poorly understood mechanisms. Micro RNAs (miRNAs) and endogenous small interfering RNAs (esiRNAs) are expressed ubiquitously; miRNAs frequently inhibit translation of protein coding genes [9], while esiRNAs are suggested to inhibit Tn mobility in Drosophila somatic cells [4,5,6] and potentially target mRNAs for degradation using a cytoplasmic RNAi mechanism [10, 11]. EsiRNAs produced in Drosophila tissues derive generally from cis-natural antisense transcripts (cis-NATs), inverted repeat containing single stranded RNAs (hairpins (hps)), and retroTns [11, 12, 14, 15]. Differences between retroTn and hp-derived esiRNA biogenesis have not been previously investigated

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.